X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13453) 13453
Newsletter (15) 15
Magazine Article (6) 6
Dissertation (4) 4
Newspaper Article (4) 4
Transcript (4) 4
Book Chapter (2) 2
Report (2) 2
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12559) 12559
antineoplastic combined chemotherapy protocols - therapeutic use (9161) 9161
male (8018) 8018
female (7658) 7658
etoposide - administration & dosage (7613) 7613
oncology (6485) 6485
middle aged (6150) 6150
adult (6090) 6090
etoposide (4756) 4756
chemotherapy (4437) 4437
aged (4429) 4429
cisplatin - administration & dosage (3564) 3564
treatment outcome (3076) 3076
etoposide - therapeutic use (2709) 2709
antineoplastic combined chemotherapy protocols - adverse effects (2682) 2682
combined modality therapy (2646) 2646
cancer (2585) 2585
lung neoplasms - drug therapy (2509) 2509
adolescent (2471) 2471
cyclophosphamide - administration & dosage (2433) 2433
cisplatin (2101) 2101
hematology (2080) 2080
doxorubicin - administration & dosage (1999) 1999
vincristine - administration & dosage (1901) 1901
prognosis (1833) 1833
etoposide - adverse effects (1742) 1742
remission induction (1601) 1601
survival rate (1599) 1599
antineoplastic combined chemotherapy protocols - administration & dosage (1561) 1561
carboplatin - administration & dosage (1539) 1539
child (1503) 1503
drug administration schedule (1462) 1462
neoplasm staging (1422) 1422
survival analysis (1387) 1387
carcinoma, small cell - drug therapy (1303) 1303
therapy (1299) 1299
retrospective studies (1292) 1292
disease-free survival (1279) 1279
bleomycin - administration & dosage (1221) 1221
cytarabine - administration & dosage (1196) 1196
child, preschool (1176) 1176
ifosfamide - administration & dosage (1172) 1172
follow-up studies (1136) 1136
antineoplastic agents - therapeutic use (1122) 1122
cyclophosphamide (1061) 1061
carboplatin (1014) 1014
tumors (951) 951
lung neoplasms - pathology (949) 949
survival (932) 932
methotrexate - administration & dosage (923) 923
aged, 80 and over (908) 908
infant (899) 899
carcinoma (889) 889
care and treatment (889) 889
pharmacology & pharmacy (858) 858
radiotherapy (835) 835
salvage therapy (820) 820
animals (809) 809
transplantation (800) 800
trial (797) 797
cisplatin - therapeutic use (791) 791
doxorubicin (787) 787
prednisone - administration & dosage (782) 782
carcinoma, non-small-cell lung - drug therapy (767) 767
dose-response relationship, drug (744) 744
young adult (734) 734
prospective studies (733) 733
recurrence (725) 725
etoposide - pharmacology (722) 722
transplantation, autologous (714) 714
lung neoplasms - mortality (702) 702
combination chemotherapy (701) 701
cisplatin - adverse effects (700) 700
cyclophosphamide - therapeutic use (697) 697
time factors (697) 697
testicular neoplasms - drug therapy (696) 696
pediatrics (694) 694
medicine & public health (681) 681
apoptosis (661) 661
phase-ii (653) 653
children (651) 651
hematopoietic stem cell transplantation (651) 651
lymphoma, non-hodgkin - drug therapy (630) 630
chemotherapy, adjuvant (623) 623
vincristine - therapeutic use (601) 601
ifosfamide (588) 588
lung neoplasms - radiotherapy (584) 584
doxorubicin - therapeutic use (577) 577
research (569) 569
surgery (566) 566
vinblastine - administration & dosage (557) 557
risk factors (535) 535
toxicity (535) 535
hodgkin disease - drug therapy (527) 527
mice (527) 527
disease (525) 525
bone marrow transplantation (519) 519
bone-marrow transplantation (517) 517
combination (516) 516
high-dose chemotherapy (507) 507
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12412) 12412
Japanese (762) 762
German (173) 173
French (148) 148
Chinese (139) 139
Spanish (68) 68
Polish (43) 43
Russian (40) 40
Italian (27) 27
Hungarian (14) 14
Czech (8) 8
Dutch (6) 6
Hebrew (6) 6
Serbian (6) 6
Portuguese (5) 5
Norwegian (2) 2
Romanian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Danish (1) 1
Lithuanian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Journal Article
Pediatric Drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Hodgkin lymphoma is one of the few cancers that affect both adults and children. Cure rates for Hodgkin lymphoma remain among the best for pediatric cancers.... 
Anthracyclines, therapeutic use | Chlormethine, therapeutic use | Alkylating-agents, therapeutic use | Brentuximab-vedotin, therapeutic use | Cisplatin, therapeutic use | Bortezomib, therapeutic use | Bleomycin, therapeutic use | Children | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2016, Volume 34, Issue 23, pp. 2690 - 2697
Journal Article
British journal of haematology, ISSN 0007-1048, 2015, Volume 169, Issue 5, pp. 672 - 682
Summary This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4... 
mogamulizumab | randomized phase II study | CCR4 | adult T‐cell leukaemia‐lymphoma | antibody therapy | Adult T-cell leukaemia-lymphoma | Mogamulizumab | Antibody therapy | Randomized phase II study | adult T-cell leukaemia-lymphoma | MONOCLONAL-ANTIBODY KW-0761 | RECEPTOR | LEUKEMIA/LYMPHOMA | HEMATOLOGY | EXPRESSION | ASSOCIATION | TRANSPLANTATION | Doxorubicin - therapeutic use | Nitrosourea Compounds - adverse effects | Prednisolone - adverse effects | Nitrosourea Compounds - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized - administration & dosage | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Carboplatin - therapeutic use | Vindesine - adverse effects | Vindesine - therapeutic use | Aged, 80 and over | Adult | Female | Prednisolone - therapeutic use | Etoposide - adverse effects | Leukemia-Lymphoma, Adult T-Cell - mortality | Etoposide - therapeutic use | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Doxorubicin - adverse effects | Chemotherapy | Lymphomas | T cells | Leukemia | Cancer | Haematological Malignancy | Research Paper
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | Radiotherapy Dosage | Doxorubicin/adverse effects | Etoposide/adverse effects | Procarbazine/adverse effects | Prospective Studies | Hodgkin Disease/drug therapy | Humans | Middle Aged | Proportional Hazards Models | Male | Treatment Outcome | Positron-Emission Tomography | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Prednisone/adverse effects | Treatment Failure | Adolescent | Survival Analysis | Adult | Female | Cyclophosphamide/adverse effects | Vincristine/adverse effects | Neoplasm Staging | Bleomycin/adverse effects | SURVIVAL | ABVD | MEDICINE, GENERAL & INTERNAL | COMBINATIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | PROGNOSTIC SCORE | RISK | STANFORD-V | PROGRESSION | MOPP/ABV HYBRID | Doxorubicin - therapeutic use | Hodgkin Disease - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - therapeutic use | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer
Journal Article
Annals of oncology, ISSN 0923-7534, 2010, Volume 21, Issue 10, pp. 2052 - 2060
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 19, pp. 3251 - 3262
Journal Article
Journal Article
Hematology, ISSN 1520-4391, 2016, Volume 2016, Issue 1, pp. 316 - 322
Treating Hodgkin lymphoma by using chemotherapy with or without radiotherapy is highly successful, with substantially fewer deaths from lymphoma than from... 
ABVD | INTERIM-PET | POSITRON-EMISSION-TOMOGRAPHY | INTERGROUP TRIAL | BREAST-CANCER RISK | INVOLVED-FIELD RADIOTHERAPY | INTERPRETATION CRITERIA | OPEN-LABEL | STAGE-III | HEMATOLOGY | INTERNATIONAL PROGNOSTIC SCORE | EDUCATION, SCIENTIFIC DISCIPLINES
Journal Article